Sort
48,018 grants matching “immunotherapy”
Human Monoclonal Antibodies against Botulinum Toxins
$419,697Kim D Janda · Scripps Research Institute, The · U01 · FY2006 · AI
Targeting Dectin-2 on Tumor-associated Macrophages for the Treatment of Cancer
$419,692Edgar G. Engleman · Stanford University · R01 · FY2022 · CA
Preventing tumor relapse with biomaterial-supported lymphocyte implants
$419,624Matthias Stephan · Fred Hutchinson Cancer Research Center · R01 · FY2015 · CA
Developmental Funds
$419,586Dario C. Altieri · Wistar Institute · P30 · FY2019 · CA
Immune response to Pneumocystis in simian model of AIDS
$419,584University Of Pittsburgh At Pittsburgh · R01 · FY2005 · HL
CHILDRENS CANCER GROUP
$419,517Children'S Hospital Of Philadelphia · U10 · FY2000 · CA
Biostatistics Facility
$419,517Daniel P. Normolle · University Of Pittsburgh At Pittsburgh · P30 · FY2023 · CA
Biostatistics Facility
$419,517Daniel P. Normolle · University Of Pittsburgh At Pittsburgh · P30 · FY2024 · CA
Biostatistics Facility
$419,517Daniel P. Normolle · University Of Pittsburgh At Pittsburgh · P30 · FY2022 · CA
Modulating Immunity through Dendritic Cell Phagocytic Receptors
$419,513Nina Bhardwaj · New York University School Of Medicine · R01 · FY2010 · AI
Evaluation of Safe and Immunogenic Dose of AD Vaccine in aged non-human primates: Prelude to Phase 1 Preventive Vaccinations
$419,490Michael G Agadjanyan · Institute For Molecular Medicine · U01 · FY2021 · AG
T cell-intrinsic metabolic control of radiotherapy
$419,461Lewis Zhichang Shi · University Of Alabama At Birmingham · R01 · FY2024 · CA
T cell-intrinsic metabolic control of radiotherapy
$419,461Lewis Zhichang Shi · University Of Alabama At Birmingham · R01 · FY2025 · CA
CEA TARGETED IMMUNOTHERAPEUTICS
$419,458Andrew A. Raubitschek · Beckman Research Institute/City Of Hope · P01 · FY2008 · CA
Combinational Immunotherapy Targeting the Melanoma-Associated Vasculature
$419,449Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · CA
Research Training In Hematology
$419,440John Patrick Sheehan · University Of Wisconsin-Madison · T32 · FY2016 · HL
Molecular Genetic Analysis of Mycobacterium tuberculosis
$419,399William Robert Jacobs · Albert Einstein College Of Medicine · R37 · FY2008 · AI
Role of the brain-immune axis in neuropsychiatric disease
$419,390Jorge Ivan Alvarez · University Of Pennsylvania · R01 · FY2024 · MH
Comprehensive identification of germline-somatic interactions
$419,382Hannah Kathryn Carter · University Of California, San Diego · R01 · FY2024 · CA
Immunotherapy for Synucleinopathies: Can Gut Microbiota Affect Efficacy?
$419,375Vinata Vedam-Mai · University Of Florida · R21 · FY2023 · NS
Developmentally regulated antigens for immunologic targeting of pediatric brain tumors
$419,375Catherine T Flores · University Of Florida · R21 · FY2023 · NS
Using Nonclassical Estrogen Signaling to Prevent Melanoma
$419,353Todd W Ridky · University Of Pennsylvania · R01 · FY2023 · CA
Directing the metabolic fate of CAR T cells
$419,337Carl H. June · University Of Pennsylvania · R01 · FY2019 · CA
Immune biological differences between Triple Negative Breast Cancer in African American and non-African American women and potential immunotherapy opportunities to improve treatment outcome
$419,283Lajos Pusztai · Yale University · R01 · FY2018 · CA
Characterization of the interaction between inflammation and cancer progression
$419,278Robert Wiltrout · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA